DHI Stock Analysis — DR Horton
Sector: Homebuilders
AI Verdict
DHI trades cheap for the growth on offer, but the market is skeptical that its scale moat will offset weak housing demand and margin pressure in the near term.
Competitive Moat
DR Horton is the largest homebuilder in the U.S. by volume, giving it scale advantages in land acquisition, supply chain management, and pricing power. Its national footprint and deep relationships with suppliers and subcontractors create cost efficiencies that smaller rivals can't easily match.
Summary
DHI's forward P/E of 12.6x with 8.0% expected EPS growth stands out in a sector facing margin pressure and weak sentiment.
Where It Stands
DHI is down -21.48% over the past year, trades at 12.6x next year's earnings (well below the industrials median of 20x), and its RSI of 45.5 signals a cooling phase after recent selling.
Key Metrics
- RSI: 45.5 — Neutral
- Trailing P/E: 13.6x
- Forward P/E: 12.6x
- PEG Ratio: 1.70
- Earnings Growth: +0.1%
- Revenue Growth: -0.0%
- Market Cap: $39.9B
- Dividend Yield: 0.01%
- 1-Year Return: -21.48%
- 52-Week High: $184.55
- 52-Week Low: $131.75
Analyst Consensus
10 Buy · 15 Hold · 1 Sell (26 analysts)
Bull Case
At 12.6x forward earnings with 8.0% expected EPS growth, you're paying a below-market multiple for a company with scale advantages and national reach.
Bear Case
If DHI's P/E falls from 12.6x to the sector's low end near 10x on further sentiment deterioration, that would mean another 20% downside even if earnings meet expectations.
Catalyst to Watch
Watch for new home sales data and margin commentary in the next earnings call—any sign of stabilizing demand or cost control could trigger a re-rating.